Philip Morris Keeps Full-Year Guidance as H1 Strength Sets Up Dynamic H2 for ZYN

Why PM keeps full-year underlying growth guidance unchanged—and how it plans to step up U.S. investments in H2 (including potential ZYN promo)

1) Why full-year underlying growth guidance is unchanged despite strong H1

A. Management says the guidance is maintained because H1 performance fits the overall trajectory, and H2 is expected to be dynamic rather than slowing

• PM explicitly states that it is “not revising the guidance” after a “great H1” and “very good news in Q2,” and that the decision is tied to an “exciting moment in the U.S.” plus the company’s broader preparation and portfolio developments. ¹
• PM characterizes this as “ample headroom” to stay within guidance while still delivering “a very dynamic H2,” and it points to growth and durability of the overall model (including smoke-free). ²
• PM further underscores that it expects “another six months… H2… of very dynamic growth for revenue” and that it is “not… expecting a slowdown in H2. Actually, quite the contrary.” ³

B. The company notes H1’s margin picture includes higher investment and expects higher SG&A in H2, but not a deterioration that forces guidance changes

• PM reports that H1 adjusted operating income margin expanded to “close to 42%,” with gross margin expansion as a key driver, while acknowledging SG&A dynamics: SG&A was “lower than expected in Q2 due to phasing,” but “increased year-on-year investment in commercial initiatives, innovation, and scale… reduced H1 margin by 30 basis points.” ⁴
• Crucially, PM then explains that it “now expect[s] higher SG&A costs in the second half… as we made the strategic decision to step up our U.S. growth investment.” ⁴
• So, the unchanged full-year guidance appears to reflect (i) gross margin and operating momentum holding up, and (ii) the fact that the incremental H2 spending is treated as a plan that fits within the guidance framework rather than something that breaks it. ⁴

C. Management ties the unchanged guidance to a balance between improved smoke-free growth drivers and mix/phasing effects (including IQOS volume mechanics)

• For revenue/growth cadence, PM explains that while H1 is “above IMS,” the full-year expectation is “shipment and IMS… broadly aligned,” implying IMS will be above shipment in H2, “and that also will have an impact on the growth of our revenue.” ³
• PM also frames 2026 as maintaining mid-to-high single digit organic growth targets and an H2 acceleration: it continues to target “organic net revenue growth of +5% to +7%” and “organic operating income growth of +7% to +9%,” and says that “for the second half, this implies a continued strong top line and an acceleration in organic operating income growth.” ⁵
• This matters because it implies the guidance is consistent with (and already accounts for) higher U.S. investment and a stronger H2 growth profile. ⁵

2) The plan for higher U.S. investments in H2

A. PM’s core rationale: use H2 investment to accelerate ZYN brand equity and portfolio expansion

• PM states that it believes it is the “right moment to accelerate U.S. investment in the second half of the year to support ZYN’s brand equity and portfolio expansion.” ⁶
• It also links the H2 push to “increased commercial activity” and notes that this dynamism will be supported by “expanding portfolio.” ⁷

B. Management describes the U.S. investment goal as optimizing growth and the bottom line (not simply spending more)

• In response to the question of whether stepped-up U.S. investments explain the unchanged guidance, management answers that the purpose is “to optimize volume growth and the bottom line growth.” ⁸
• PM also says the U.S. situation is now a “great moment,” with capacity to deliver “very strong growth while accelerating our investment in the U.S.” ⁸

C. What it says about the nature of spending: commercial activity and marketing—especially around ZYN—and some evidence of reduced promotions in Q2

• PM indicates that accelerating ZYN requires “a lot of marketing, commercial activity at the point of sales.” ⁹
• It also explains a promotional cadence effect: management says Q2 promotional activity was “more reduced” and that this is why revenue was “close to flat year-over-year” while volume was “slightly up.” ⁹
• Separately, PM notes that the sequential improvement in the U.S. in Q2 includes “reduced sales promotion as we prepared for new product launches,” reflecting a lead-up period rather than a sustained reduction. ¹⁰

3) Will H2 promotional spending behind ZYN rise? (and how PM addresses the question)

A. PM signals more commercial/marketing activity in H2, but avoids committing to “a big step-up” in promotional spend details

• When asked whether a “big step-up in promotional spend behind ZYN” should be expected, management does not give a numeric or explicit promotional-spend forecast; instead it reiterates that the aim is optimizing volume and bottom-line growth and that this is the degree of detail it can provide. ¹¹⁸
• PM also indicates ZYN promotion may be part of a broader commercial toolkit: it says it will pull “every lever we can” to accelerate growth of ZYN, and that “of course” this comes with marketing and point-of-sale activity. ⁹

B. It provides directional context on promotions: Q2 was reduced; H2 will include increased commercial activity and portfolio expansion

• The clearest operational clue in the transcript is comparative: Q2 had “more reduced” promotional activity, corresponding to near-flat revenue YoY. ⁹
• Looking to H2, PM expects “dynamism of ZYN to be enhanced by our expanding portfolio and increased commercial activity.” ⁷

C. PM’s positioning effort suggests promotional intensity is being used to strengthen premium leadership rather than being framed as ad-hoc discounting

• PM says it is implementing commercial initiatives “to optimize ZYN’s premium positioning and enhance consumer value perception.” ¹²
• It also stresses regulatory/brand differentiation and consumer trust as a foundation for long-term growth (including MRTP-related marketing permission for 20 SKUs and the risk reduction claim used in marketing). ¹²
• Management explicitly refuses to comment on “price action” in advance, calling it “anti-competitive,” but still maintains ZYN will “stay as the leading premium brand.” ⁹

4) Practical interpretation: why unchanged guidance is consistent with higher H2 U.S. investments

Putting the excerpts together, PM’s logic appears to be:

1. H1 is strong and fits the planned trajectory, so the company does not need to revise full-year targets. ¹²
2. H2 is expected to be even more dynamic (revenue and operating income acceleration), and the company already frames its guidance around that acceleration. ³⁵
3. Higher H2 U.S. investment will raise SG&A, but management expects the profit model to remain intact because gross margin and operating momentum are expected to support the guidance. ⁴
4. U.S. investment is targeted to ZYN brand equity and portfolio expansion, with marketing and point-of-sale commercial activity as key mechanisms, and with promotions likely shifting from Q2’s reduced stance to a more active posture in H2—without PM offering a “how much promotion” number. ⁶⁷⁹¹¹⁸

In other words, management’s “unchanged guidance” stance is less about denying higher spending and more about asserting that the planned increase is already embedded in the full-year profitability and growth trajectory. ⁴⁵